Psychedelic Drug Treatments: Assisting the Therapeutic Process
provides information about current and quite viable investigation into
reviving and progressing with neurological research that began in the
middle of the 20th century and was brought to a halt when certain drugs
were banned in the 1970s. Using a question/answer format, the book will
introduce you to the way in which the chemical compounds known as
psychedelics affect the brain, provide you with the definitions of key
terms particular to the neurological and psychological vocabulary,
describe the specific disorders that can realistically be helped or
relieved through treatment with psychedelics, and offer information with
regard to current research being conducted in the field. This text will
discuss the history of the earlier research efforts and will examine the
likelihood of a resurgence of interest in the successful development of
methods and practices of clinical therapy assisted by psychedelic drugs.
The purpose of this volume is to promote an understanding of the use of
psychedelics as tools to assist therapy and to challenge the 40-year-old
prejudices against research into the possible benefits of these drugs.
Features:
-Questions and answers about the history, research, and treatments
related to psychedelic drugs
-Makes a case for the re-evaluation of psychedelics -- LSD, MDMA
('ecstasy'), DMT, psilocybin, ayahuasca, peyote, ibogaine, and more --
and their clinical potential for treating a range of conditions from
post-traumatic stress disorder and depression to autism and cluster
headaches.
-Includes numerous in-text resources such as links to Web sites, videos,
articles, blogs, etc. from NIH, FDA, YouTube, and university/clinical
studies
